Download Citation
Article Source:
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
Hölttä M,
Hansson O,
Andreasson U,
Hertze J,
Minthon L,
et al.
(2013)
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease.
PLOS ONE 8(6): e66381.
https://doi.org/10.1371/journal.pone.0066381